Notice Number: NOT-HL-05-113
Release Date: April 5, 2005
Response Date: June 17, 2005
The NHLBI is soliciting comments and ideas on how NHLBI-supported resources in genetics and genomics can be used to facilitate the research of investigators at minority-serving institutions.
Investigators at some minority-serving institutions (MSIs) may not have adequate access or the appropriate research resources to use genetic and genomic technologies and applications in their research studies. NHLBI-supported resources in genetics and genomics (e.g., Programs in Genomic Applications, NHLBI Shared Microarray Facilities, NHLBI Clinical Proteomics Programs, etc.) have been developed to advance scientific discovery in health and disease by providing information and education, tools, and resources to link genes to biological function (see http://www.nhlbi.nih.gov/resources/index.htm for more information). This information is freely available to the research community. While such information and resources are widely disseminated, they may not be as readily available to investigators at MSIs. Therefore, there is a need to promote genetic, genomic, and proteomic resources, as well as their application and availability, to investigators at MSIs.
The NHLBI seeks your help in identifying how to make genetic and genomic resources available to investigators at MSIs. Specifically, we are interested in understanding
(a) the needs and barriers to perform genetic, genomic, and proteomic research at MSIs and (b) how NHLBI can assist in meeting the needs and overcoming the barriers.
Your thoughts, ideas, and suggestions will be used to guide future NHLBI activities designed to expedite the use of genetic and genomic resources at MSIs and their application to biomedical research questions in an effort to improve public health. Respondents are asked to comment on one or more of the issues listed below, but should not feel compelled to address all of them.
The NHLBI would like your thoughts and comments on the following areas:
Do barriers exist in the use of genetic, genomic, and proteomic research resources and information (e.g., Programs in Genomic Applications, NHLBI Shared Microarray Facilities, NHLBI Clinical Proteomics Programs, etc.) by investigators at MSIs? If so, what are the barriers? What needs should be addressed?
How can these or other barriers in performing genetic, genomic, and proteomic research at MSIs be overcome?
This request for information is for planning purposes only and shall not be construed as a solicitation for applications or as an obligation on the part of the government. The government will not pay for the preparation of any information submitted or for the government's use of that information.
Responses will be shared with the NHLBI Board of Extramural Advisors and the NHLBI Advisory Council. If anonymity is requested, please state at the beginning of your response.
Please send comments (and include the Notice number HL-05-113 in the subject line) to NHLBI_DHVDData@mail.nih.gov by June 17, 2005. Responses may also be sent by letter or FAX to the following address:
NHLBI/DHVD Data Coordinator
c/o Ms. Tawanna Meadows
Two Rockledge Center
6701 Rockledge Drive
Suite 9044, MSC 7940
Bethesda, MD 20892-7940
Telephone: (301) 435-0513
FAX: (301) 480-1336
Acknowledgement of receipt of responses will not be made, nor will respondents be notified of the government's assessment of the information received. No basis for claims against the government shall arise as a result of response to this request for information, or in the government's use of such information as either part of our evaluation process or in developing specifications for any subsequent announcement. Responses will be held in a confidential manner.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.